These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3918355)

  • 21. Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):549-52. PubMed ID: 812334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung transplantation for non-cystic fibrosis bronchiectasis.
    Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
    Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isolation and characterization of non-typeable Haemophilus influenzae from the sputum of adult cystic fibrosis patients.
    Bilton D; Pye A; Johnson MM; Mitchell JL; Dodd M; Webb AK; Stockley RA; Hill SL
    Eur Respir J; 1995 Jun; 8(6):948-53. PubMed ID: 7589381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucoid Escherichia coli in cystic fibrosis.
    Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
    N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
    [No Abstract]   [Full Text] [Related]  

  • 28. Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time.
    Crull MR; Ramos KJ; Caldwell E; Mayer-Hamblett N; Aitken ML; Goss CH
    BMC Pulm Med; 2016 Dec; 16(1):176. PubMed ID: 27927212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cystic fibrosis in adults--clinical aspects].
    Skorupa W; Wierzbicka M; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):198-204. PubMed ID: 9489415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of biotypes of Haemophilus influenzae and H parainfluenzae in patients with cystic fibrosis.
    Watson KC; Kerr EJ; Hinks CA
    J Clin Pathol; 1985 Jul; 38(7):750-3. PubMed ID: 3874885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis.
    Taylor RF; Morgan DW; Nicholson PS; Mackay IS; Hodson ME; Pitt TL
    Thorax; 1992 Jun; 47(6):426-8. PubMed ID: 1496501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
    Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
    Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis.
    Duff RM; Simmonds NJ; Davies JC; Wilson R; Alton EW; Pantelidis P; Cox MJ; Cookson WO; Bilton D; Moffatt MF
    Eur Respir J; 2013 Apr; 41(4):991-3. PubMed ID: 23543647
    [No Abstract]   [Full Text] [Related]  

  • 34. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
    Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
    Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with Cystic Fibrosis.
    Berkhout MC; Klerx-Melis F; Fokkens WJ; Nuijsink M; van Aalderen WM; Heijerman HG
    J Cyst Fibros; 2016 Nov; 15(6):816-824. PubMed ID: 27049043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.